Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust?
Background: Generic substitution (GS), is a cost-containment strategy meant to contain pharmaceutical expenditure without compromising health objectives. In order to shape GS into a policy that is both efficient and safe it is crucial to understand which factors are most important for patients’ trus...
Main Authors: | Olsson E, Svensberg K, Wallach-Kildemoes H, Carlsson E, Hällkvist C, Kaae S, Kälvemark Sporrong S. |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2018-12-01
|
Series: | Pharmacy Practice |
Subjects: | |
Online Access: | https://www.pharmacypractice.org/journal/index.php/pp/article/view/1298 |
Similar Items
-
Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01) -
Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01) -
Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
by: Howard, Robert E.
Published: (2014) -
Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01) -
Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)